ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1551

Correlation of Individual HAQ Questions with Disease Activity Measures in Psoriatic Arthritis: Implications for Instrument Reduction

Denis Choquette1, Carter Thorne2, Majed Khraishi3, Isabelle Fortin4, Regan Arendse5, Andrew Chow6, John Kelsall7, Milton Baker8, Julie Vaillancourt9, John S. Sampalis9, Francois Nantel10, Allen J Lehman11, Susan Otawa11 and May Shawi10, 1Rheumatology, Notre Dame Hospital, Montreal, QC, Canada, 2Southlake Regional Health Centre, Newmarket, ON, Canada, 3Nexus Clinical Research, St John's, NF, Canada, 4Centre de Rhumatologie de l'Est du Québec, Rimouski, QC, Canada, 5University of Saskatchewan, Saskatoon, SK, Canada, 6University of Toronto, McMaster University, Credit Valley Rheumatology, Mississauga, ON, Canada, 7The Mary Pack Arthritis Centre, Vancouver, BC, Canada, 8University of Victoria, Victoria, BC, Canada, 9JSS Medical Research, Montreal, QC, Canada, 10Janssen Inc., Toronto, ON, Canada, 11Medical Affairs, Janssen Inc., Toronto, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Health Assessment Questionnaire, infliximab, PRO, psoriatic arthritis and registry

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment II

Session Type: Abstract Submissions (ACR)

Background/Purpose The Health Assessment Questionnaire (HAQ) is commonly used for assessing patient-reported functional status and disease activity in psoriatic arthritis (PsA). However, it has been critiqued for being time-consuming, not easily scored and thus, not contributing to decisions in routine care (1,2). The aim of this analysis was to describe the correlation of individual HAQ questions with patient and physician reported measures used in PsA and to examine whether the instrument could be reduced to better reflect routine clinical practice.

Methods BioTRAC is an ongoing, prospective registry of patients initiating treatment for RA, AS, or PsA with infliximab or golimumab as first biologics or after <6 months of biologic treatment. Data from PsA patients treated with infliximab or golimumab in 2006-2013 were used. The correlation of each HAQ question with patient and physician (pain, patient global assessment (PtGA), SJC28, TJC28 and physician global assessment (MDGA)) reported measures were described with the Pearson's correlation coefficient. The impact of each HAQ question on the need for help in each HAQ domain was assessed with logistic regression. Factor analysis was used to assess the variability due to each question in HAQ.

Results A total of 183 PsA patients with 596 HAQ assessments were included. Individual HAQ questions correlated at different extents with each PsA measures (Table 1). All questions showed higher correlations with PtGA and pain compared to MDGA. Regarding patient reported outcomes, Question 5A (“Wash / dry your entire body”) showed the highest correlation, specifically with pain.

The majority of HAQ questions were significantly associated with the need for help within their corresponding ability category, with the exception of questions Q3B, Q3C, Q4B, Q5C and Q8B.

The results of factor analysis showed that 2 (Q1A and Q3B) out of the 20 HAQ questions accounted for 61.5% of its matrix variance, suggesting that the question on the ability to “dress, tie shoelaces and do buttons”, as well as the question on the ability to “lift a full cup or glass” may be the main drivers of HAQ in PsA.

Conclusion Variability exists in the correlation of individual HAQ questions with patient and physician reported PsA measures. Pain and PtGA are significantly associated with the various domains of HAQ, while clinical outcomes (SJC28 and TJC28) and MDGA are less important. Among PsA patients, the HAQ is driven by components related to dressing and grooming and to eating abilities, suggesting that PsA patients may be facing different challenges than RA patients. This may have implications from an occupational health perspective and in the design of a shorter self-report instrument more suitable for PsA patients. 

 

Table 1. Correlation* between Individual HAQ Questions and PsA Outcome Measures

HAQ Questions

Pain

PtGA

SJC28

TJC28

MDGA

Dressing and Grooming (Q1 A/B)

0.57/0.42

0.53/0.37

0.35/0.28

0.39/0.35

0.46/0.33

Arising (Q2 A/B)

0.57/0.56

0.56/0.54

0.28/0.27

0.37/0.37

0.41/0.40

Eating (Q3 A/B/C)

0.41/0.69/0.43

0.35/0.32/0.41

0.32/0.24/0.31

0.35/0.28/0.37

0.31/0.26/0.37

Walking (Q4 A/B)

0.51/0.57

0.49/0.54

0.29/0.33

0.37/0.39

0.43/0.43

Hygiene (Q5 A/B/C)

0.67/0.48/0.53

0.45/0.44/0.48

0.27/0.18/0.25

0.34/0.34/0.32

0.37/0.32/0.31

Reach (Q6 A/B)

0.38/0.57

0.40/0.53

0.26/0.29

0.52/0.35

0.36/0.40

Grip (Q7 A/B/C)

0.34/0.43/0.54

0.33/0.39/0.30

0.28/0.28/0.27

0.37/0.35/0.39

0.29/0.35/0.27

Activities (Q8 A/B/C)

0.56/0.57/0.55

0.53/0.55/0.53

0.27/0.27

0.37/0.38/0.41

0.40/0.40/0.42

HAQ-DI score

0.67

0.63

0.38

0.50

0.51

* Levels of correlation are Weak: r <0.30; Moderate: r =0.30 - 0.39; Strong: r =0.40 - 0.69; and

Very Strong: r ≥0.70

 

References:

1.       Khanna D et al. Arthritis Care Res. 2011;63:S486-S490.

2.       Holliman K. The Rheumatologist. Jan 2013.


Disclosure:

D. Choquette,

Notre-Dame Hospital, Quebec, Canada,

3,

AbbVie,

5,

Amgen,

5,

Celgene,

5,

BMS Canada,

5,

Janssen Pharmaceutica Product, L.P.,

5,

Pfizer Inc,

5;

C. Thorne,

Janssen Inc.,

5;

M. Khraishi,

Janssen Inc.,

5;

I. Fortin,

Janssen Inc.,

5;

R. Arendse,

Janssen Inc.,

5;

A. Chow,

Janssen Inc.,

5;

J. Kelsall,

Janssen Inc.,

5;

M. Baker,

Janssen Inc.,

5;

J. Vaillancourt,
None;

J. S. Sampalis,
None;

F. Nantel,

Janssen Inc.,

3;

A. J. Lehman,

Janssen Inc.,

3;

S. Otawa,

Janssen Inc.,

3;

M. Shawi,

Janssen Inc.,

3.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-of-individual-haq-questions-with-disease-activity-measures-in-psoriatic-arthritis-implications-for-instrument-reduction/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology